MedTrace Logo

Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Patients

NCT06394934 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4188

Last updated 2024-05-01

No results posted yet for this study

Summary

This observational study investigates the correlation between home blood pressure variability (BPV) and arteriosclerosis, alongside metabolic indicators, in hypertensive patients over a three-year period. The research specifically focuses on the predictive value of home BPV for major adverse cardiovascular events (MACE) including myocardial infarction, stroke, and heart failure hospitalizations. Utilizing a mobile application called Healthscan for daily BP monitoring, the study aims to enhance the understanding of how BPV impacts cardiovascular and metabolic health in a real-world setting.

Conditions

  • Hypertension
  • Blood Pressure Monitoring, Home
  • Arteriosclerosis
  • Metabolic Syndrome X

Interventions

BEHAVIORAL

Healthscan App

Participants will use the Healthscan mobile application to monitor and record their daily blood pressure at home. The app allows participants to enter their BP measurements, which are then used to calculate blood pressure variability (BPV). The app's use is intended as a non-invasive, practical tool for patient self-management and longitudinal health monitoring in hypertensive individuals.

Sponsors & Collaborators

  • Korean Society of Hypertension

    collaborator OTHER

  • Korea University Anam Hospital

    lead OTHER

Principal Investigators

  • Hyung Joon Joo, MD PhD · Korea University Anam Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-09
Primary Completion
2024-12-31
Completion
2029-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06394934 on ClinicalTrials.gov